A phase 3b, randomized, open-label, parallel group, multicenter trial assessing the efficacy of Exubera vs lispro introduced into a Lantus based regimen in suboptimally controlled patients with type 2 diabetes mellitus.
Phase of Trial: Phase III
Latest Information Update: 30 Mar 2010
At a glance
- Drugs Antihyperglycaemics; Insulin; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 26 Feb 2009 Actual patient number changed from 450 to 190 as reported by ClinicalTrials.gov.
- 26 Feb 2009 Actual end date changed from Jul 2008 to Aug 2008 as reported by ClinicalTrials.gov.